OmicLab Limited is a high-tech enterprise dedicated to precision medicine, integrating bioinformatics and machine learning technology development, multi-omics data analysis, and customised genetic testing. The company is committed to building a digital analysis and testing platform with advanced bioinformatics technology, machine learning, and sequencing techniques to promote research in the field of life and health and the translation of industry-academia-research. We provide customers with reliable and precise medical services and solutions.
Relying on leading technology and a complete multi-omics data analysis chain, the company launched the CombCure precision cancer diagnosis and treatment platform to offer digital detection solutions for hospitals and clinical testing institutions to provide patients with faster and safer precision treatment solutions. In the future, OmicLab Limited will offer more advanced digital platform solutions with better services and contribute to the goal of utilising gene technology to benefit human health.
Dr Zhao Zicheng (Alumnus, Dept.of Computer Science, CityU)
Dr Chen Lingxi (Postdoc, Dept.of Computer Science, CityU)
Miss Li Shiying (PhD Student, Dept.of Computer Science, CityU)
Miss Wang Mengyao (PhD Student, Dept.of Computer Science, CityU)
Miss Wang Yanfei (Research Assistant, Dept.of Computer Science, CityU)
Miss Li Mengyao (Graduate, Wuhan University of Technology)
Miss Wang Xueying (PhD Student, Dept.of Computer Science, CityU)
(Info based on the company's application form)
- CityU HK Tech 300 Angel Fund (2021)
- CityU HK Tech 300 Seed Fund (2021)
- Silver Award in the 12th Challenge Cup – China Youth Innovation and Entrepreneurship National Competition (2020)
- Silver Award in the 6th China International College Students’ “Internet Plus” Innovation and Entrepreneurship Competition (2020)